Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?

European Journal of Radiology

Volumn 41, Issue 3, 2002, Pages 184-191

  Basilico, Raffaella ^a   Blomley, Martin J K ^b   Harvey, Christopher J ^b   Filippone, Antonella ^a   Heckemann, Rolf A ^b   Eckersley, Robert J ^b   Cosgrove, David O ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Doppler sonography; Focal liver lesions; Ultrasound contrast agents

Indexed keywords

BLOOD VESSELS; DOPPLER EFFECT; PATIENT TREATMENT; TOMOGRAPHY;

COMPUTED TOMOGRAPHY; MICROBUBBLES;

RADIOLOGY;

CONTRAST MEDIUM; SONOVUE;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; DIAGNOSTIC IMAGING; HUMAN; INTERMETHOD COMPARISON; LIVER HEMANGIOMA; LIVER INJURY; LIVER METASTASIS; MEDICAL ASSESSMENT; NODULAR HYPERPLASIA; PRIORITY JOURNAL; RADIAL ARTERY; RATING SCALE; SIGNAL DETECTION; UNITED STATES; VASCULARIZATION; VIDEORECORDING;

ADULT; AGED; CONTRAST MEDIA; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, DOPPLER;

EID: 0036180607     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(01)00459-4     Document Type: Article

References (25)

1. Color Doppler flow imaging of liver tumors
2. Color flow Doppler characterisation of focal hepatic lesions
3. Power Doppler US: A potentially useful alternative to mean frequency-based color Doppler US
4. Color Doppler ultrasonography in the differential diagnosis of focal hepatic lesions: The SHU 508 A (Levovist) experience
5. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: Correlation with angiographic findings
6. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: A preliminary study
7. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: Preliminary study
8. Optimising ultrasound imaging instruments for contrast agents
9. Harmonic imaging: Principles and preliminary results
10. Harmonic hepatic US with microbubble contrast agent: Initial experience showing improved characterisation of hemangioma, hepatocellular carcinoma, and metastasis
11. Hepatic tumors: Contrast agent-enhancement patterns with Pulse-Inversion harmonic US
12. Pulse Inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast
13. Tumor angiogenesis
14. Assessment of tumor vascularity in hepatocellular carcinoma: Comparison of power Doppler US and color Doppler US
15. Power versus conventional color Doppler sonography: Comparison in the depiction of vasculature in liver tumors
16. Evaluation of tumor angiogenesis with US: Imaging, Doppler and contrast agents
17. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors
18. Improved characterisation of focal liver tumours: Dynamic power Doppler imaging using NC100100 echo-enhancer
19. Hepatocellular carcinoma: Power Doppler US with a contrast agent - Preliminary results
20. Contrast enhanced power Doppler sonography: Improved detection of characteristic flow patterns in focal liver lesions
21. Echo-enhanced Doppler sonography of focal nodular hyperplasia of the liver
22. Vascular of hepatocellular carcinoma: Assessment with contrast-enhanced second harmonic versus conventional power Doppler US
23. Infusion versus bolus of an ultrasound contrast agent: In vivo dose-response measurements of BR1
24. Contrast-specific instrumentation and its potential applications
25. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: Preliminary results